Immediate Impact

1 by Nobel laureates 3 from Science/Nature 58 standout
Sub-graph 1 of 21

Citing Papers

Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
2024 Standout
2 intermediate papers

Works of Gerald E. Hall being referenced

Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade
2018

Author Peers

Author Last Decade Papers Cites
Gerald E. Hall 222 213 73 124 16 443
Sukanya Chakraborty 260 127 17 79 15 451
Marc Azémar 152 149 35 168 15 481
Kinnimulki Vijayachandra 362 96 56 48 10 478
Laurie Tonon 245 169 14 103 25 447
Jim Peacock 292 209 68 23 13 460
Roberto Montes de Oca Luna 375 292 78 17 10 461
Athanasios Kotsinas 345 119 10 69 15 474
Martine Darwish 223 167 5 94 16 418
Yujiro Naito 122 173 22 136 28 376
Chiara Secondini 167 195 20 133 9 421

All Works

Loading papers...

Rankless by CCL
2026